Sarasota, FL -- (SBWIRE) -- 04/29/2019 -- According to the report, the global cardiac pacemaker market was valued at approximately USD 4539 million in 2018 and is expected to generate around USD 7135 million by 2025, at a CAGR of around 7.0% between 2019 and 2025.

A pacemaker is a small device that keeps the heart beats regular and at the right pace along with helping to reduce the symptoms of slow heartbeats. It is an artificial device implanted underneath the chest skin that produces electrical pulses with low-energy to control the abnormal heart rhythm. Pacemakers are used in several medical conditions related to the heart and its rhythms, such as heart block, long QT syndrome (LQTS), arrhythmia, and atrial fibrillation. Pacemakers are one of the most preferred choices of treatments for cardiovascular disorders due to their non-invasive nature.

DOWNLOAD FREE PDF BROCHURE @ http://bit.ly/2VvDYda

The growing invasion of cardiovascular diseases together with the increasing awareness about the consequences of life-threatening diseases is estimated to drive the global pacemaker devices market over the estimated timeframe. The increasing prevalence of cardiovascular diseases across the globe is creating the demand for a solution that can deliver the services to improve the health of patients at a relatively lower and affordable cost. This is another factor that is likely to fuel the global cardiac pacemaker market in the future. However, the high cost of pacemakers may hinder the growth of the global pacemaker devices market in the future. Approximately 17.5 million people died from cardiovascular disorders in 2015, i.e., 31% of all the global deaths. Furthermore, the availability and access to reimbursement for the implantation of pacemakers will help in decreasing patients' economic burden, which, in turn, is anticipated to further fuel the market prominently over the forecast time period.

By product type, the cardiac pacemaker market is segmented into external pacemaker devices and implantable pacemaker devices. The implantable pacemaker devices are expected to register the highest growth rate over the forecast time period, due to the technological advancements related to the product coupled with its ease and convenience to the patients. The application segment includes arrhythmia, atrial fibrillation, bradycardia, tachycardia, and others. Arrhythmia is estimated to show the highest CAGR over the forecast time period, owing to the rising prevalence of arrhythmia globally. By technology, the market is segmented into a single chamber, dual chamber, and biventricular. Biventricular technology is anticipated to exhibit the highest CAGR over the forecast time period. The biventricular is a special type of pacemaker that is attached to the atrium and right and left ventricles of the heart. Biventricular pacemaker device is also known as cardiac resynchronization therapy (CRT) and is used in cardiac resynchronization therapy. By end-user, the market is segmented into hospitals, ambulatory surgical centers, and cardiology clinics. Hospitals are estimated to dominate the global cardiac pacemaker market over the forecast time period.

By region, the global cardiac pacemaker market includes Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. North America is projected to lead the global cardiac pacemaker market over the forecast period, owing to the well-established healthcare reforms, continuous extensive research activities, rising adoption of pacemaker devices with the increasing prevalence of cardiac disorders, and rising product advancement techniques. Europe was the second largest market globally in 2018 followed by the Asia Pacific. The Asia Pacific cardiac pacemaker market is projected to register the highest growth rate over the forecast time period, owing to the increasing disease burden and rising disposable income coupled with growing government initiatives with favorable reimbursement scenario. The Middle Eastern and African cardiac pacemaker market is expected to experience moderate growth in the years to come.

Some key players of the global cardiac pacemaker market are Medtronic PLC, ZOLL Medical Corporation, Vitatron, BIOTRONIK, Inc., St. Jude Medical, Boston Scientific Corporation, MEDICO S.p.A., Cordis, Inc., Abbott Laboratories, and Pacetronix, among others.

Get FREE Sample Research Report @ http://bit.ly/2W2fdm1

Global Cardiac Pacemaker Market: Product Type Analysis

External Pacemaker Devices
Implantable Pacemaker Devices

Global Cardiac Pacemaker Market: Application Analysis

Arrhythmia
Atrial Fibrillation
Bradycardia
Tachycardia
Others

Global Cardiac Pacemaker Market: Technology Analysis

Single Chamber
Dual Chamber
Biventricular

Global Cardiac Pacemaker Market: End-User Analysis

Hospitals
Ambulatory Surgical Centers
Cardiology Clinics

GET FREE PDF BROCHURE @ http://bit.ly/2VvDYda

Global Cardiac Pacemaker Market: Regional Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

About Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.